Cada día hay más evidencia científica que apoya el uso de esta terapia en varias enfermedades neurológicas.
Having regard to Regulation (EC) No #/# of the European Parliament and of the Council of # July # on a revised Community eco-label award scheme, and in particular the second subparagraph of Article # thereofscielo-abstract scielo-abstract
] ¿Cuáles son los signos de la enfermedad neurológica?
Can they become obstacles to diversity if they achieve significant market share? [ Main page | Previous | Table of contents | Next ]Literature Literature